Skip to main content

As biotech and informatics converge, how are VCs adapting? – MedCity News

By March 16, 2017News
chemistry-atoms-pixa

chemistry-atoms-pixa

It’s fair to say we’ve entered a new era in biotech and pharma. Whether it’s diagnostics, drug development or medtech; informatics, mathematics and machine learning are marching their way in. Biology is being digitized. Big Data is taking population-wide information and distilling it down for treatment plans at an individualized scale.

The science within startups is evolving.

{iframe}http://medcitynews.com/2017/03/biotech-informatics-converge-vcs/?utm_source=hs_email&utm_medium=email&utm_content=45162940&_hsenc=p2ANqtz-_QPdI0cHshYdBRIwTdeNKWFsn2Zk2ddiQ1XXHz_oSnSj_JQV0xHt9LmjEVFvB0bh9SgNnJNGcywJ2uzilcE7jjzntWKQ&_hsmi=45162940{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.